Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Breast Cancer Research : BCR|April 2, 2014
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancerJasmeet Singh, Yelena Novik, Stacey Stein, et al.JCO Oncology Practice|February 3, 2021
Moving Beyond the Momentum: Innovative Approaches to Clinical Trial ImplementationCathy Eng, Emerson Y Chen, Jane Rogers, et al.Cancer|December 22, 2020
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancerMichael Cecchini, Jeremy S Kortmansky, Can Cui, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2020
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract CancerLipika Goyal, Cynthia Sirard, Michael Schrag, et al.Clinical and Translational Radiation Oncology|January 4, 2021
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisJoseph A Miccio, Wesley J Talcott, Timil Patel, et al.British Journal of Cancer|December 22, 2023
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinomaMichael Cecchini, James M Cleary, Yu Shyr, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 7, 2017
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.JAMA Oncology|June 20, 2024
Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled TrialMichael Cecchini, Ronald R Salem, Marie Robert, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2021
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Michael I D'Angelica, Daniel E Abbott, et al.Pageof 4